Pain medicine case reports · 2026
A Novel Case Report of Closed-Loop Spinal Cord Stimulation for Neuropathic Pain in Cervical Spinal Cord Injury.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dovlatyan Ruben, Jevotovsky David, Shah Jarna R, Petersen Erika A
Аннотация
BACKGROUND: Neuropathic pain after spinal cord injury (SCI) is common and often refractory. Closed-loop spinal cord stimulation (CL-SCS) is a novel intervention that adjusts stimulation based on evoked compound action potentials in real time, but its use for pain in complete SCI is not well described.
CASE REPORT: A 45-year-old man with complete C6-C7 SCI developed severe, diffuse neuropathic pain below the injury level refractory to multiple medications, an intrathecal fentanyl pump trial, and ketamine infusions. With extensive epidural scarring, a staged buried CL-SCS trial with a combined open/percutaneous approach implanted bilateral C2-C5 leads. Trial stimulation produced complete analgesia. After internalization, pain improved to 4/10 on the Numeric Rating Scale at 3 months, with sustained 50-60% subjective improvement through 12 months. A wound complication at 11 months prompted surgical washout. Persistent concern for device colonization ultimately led to explantation at 18 months.
CONCLUSIONS: CL-SCS may provide meaningful, sustained analgesia and functional benefit in select patients with complete cervical SCI. Systematic studies are needed to quantify benefit, durability, and risk.
CASE REPORT: A 45-year-old man with complete C6-C7 SCI developed severe, diffuse neuropathic pain below the injury level refractory to multiple medications, an intrathecal fentanyl pump trial, and ketamine infusions. With extensive epidural scarring, a staged buried CL-SCS trial with a combined open/percutaneous approach implanted bilateral C2-C5 leads. Trial stimulation produced complete analgesia. After internalization, pain improved to 4/10 on the Numeric Rating Scale at 3 months, with sustained 50-60% subjective improvement through 12 months. A wound complication at 11 months prompted surgical washout. Persistent concern for device colonization ultimately led to explantation at 18 months.
CONCLUSIONS: CL-SCS may provide meaningful, sustained analgesia and functional benefit in select patients with complete cervical SCI. Systematic studies are needed to quantify benefit, durability, and risk.